Ortho-McNeil Pharmaceutical Co., the manufacturer of the popular birth-control patch Ortho Evra, found itself in court again on Wednesday as additional lawsuits were filed by women who claim the contraceptive caused serious illnesses and at least one death.
GlaxoSmithKline PLC is dishing out $63.8 million to settle claims in a class action lawsuit that it marketed its antidepressant drug Paxil to kids and teenagers while hiding information about the drug’s safety.
On the same day that generic maker Apotex begged the Federal Circuit Court of Appeals to allow it to make a copycat version of the drug Plavix, two plaintiffs firms Tuesday served Plavix makers Bristol-Myers Squibb and Sanofi-Aventis with the first personal injury lawsuit over the drug.
A woman who claims she suffered because of defective knee implants has targeted Encore Medical Corp. in a 10-count complaint alleging the company committed fraud when it said its prosthetic knee devices were safe and accusing the doctor that implanted the device of medical battery.
Even with nearly 24,000 Vioxx-related lawsuits filed around the country, Merck & Co. is still reportedly looking to thwart any consolidation of cases.
A federal judge has granted class action status to a lawsuit brought by more than 11,000 people who received one of St. Jude Medical Inc.’s allegedly defective Silzone heart valves.
Bayer AG has appointed independent counsel to review the company’s failure to disclose to the U.S. Food and Drug Administration a study that revealed health risks posed by its heart surgery drug, Trasylol.
The U.S. Food and Drug Administration cleared a silicone breast implant manufacturer of committing any wrongdoing after reviewing allegations by a former employee that the company withheld data on the safety of the implants, the FDA said Thursday.
Eli Lilly & Co. has been hit with another lawsuit over it schizophrenia drug, Zyprexa, adding to the pharmaceutical company’s legal woes over one of its top-selling drugs.
In a surprise turnaround, a Pennsylvania state court judge has declared a mistrial in the first state court trial over Wyeth’s hormone replacement therapy drug, overturning a jury’s finding that Prempro was a cause of a woman's breast cancer.
Congress should better regulate and should give more money to the U.S. Food and Drug Administration so it can make drugs safer for consumers, according to a report published Monday.
A federal appeals court reinstated a case Thursday brought by several Michigan residents who say they were hurt from taking the diabetes drug, Rezulin, which was yanked from the market in 2000.
After six days of deliberations, jurors in the first state court trial over Wyeth’s hormone replacement therapy drugs finally reached a decision on Wednesday, finding that Prempro was a cause of a woman's breast cancer and ordering the drug maker to shell out $1 million in compensatory damages.
An association of doctors who implant defibrillators and pacemakers has recommended that the U.S. Food and Drug Administration enhance existing post-market surveillance databases and better communicate with the public about device malfunctions.
Jurors in the first state court trial over claims that Wyeth’s hormone replacement therapy drugs increase the risk of heart disease, stroke and cancer remained deadlocked on Thursday, with the judge ordering them back to court on Friday to attempt to reach a verdict.
Merck & Co. said late Tuesday that a jury had cleared the company of responsibility for a Kentucky man's heart attack, marking the company’s second federal win in the slew of litigation it faces over its painkiller Vioxx.
Europe’s top drug agency has launched another review of commonly used anti-inflammatory drugs amid concerns over a link to heightened risk of heart attacks.
Pharmaceutical giant Merck & Co. may be plunged into even deeper hot water in the next few days over its painkiller Vioxx, as plaintiffs attorneys rush to file additional lawsuits ahead of a September 30 deadline.
The Food & Drug Administration has ordered a first round of studies to address the safety of medicines already on the market. Attention deficit hyperactivity disorder, osteoporosis and contraceptive medications will be the first to face scrutiny.
Natural foods company AMS Health Sciences Inc. settled a contentious wrongful-death claim Wednesday stemming from its past sales of ephedra-based products. The lawsuit was the last in a series of claims against AMS over the now-banned herbal product.